Adjuvant ipilimumab improves recurrence-free survival in high-risk stage III melanoma

HPV-targeted adoptive T Cell therapy may provide a new personalised strategy for advanced cervical cancer

Comment: HPV-targeted adoptive T cell therapy may provide a new strategy for advanced cervical cancer

Comment: Adjuvant ipilimumab in high-risk melanoma

Comment: PD-1 targeting MK-3475 gives long-term responses in melanoma

Comment: Immunotherapy combo increases median survival in advanced melanoma

Success for ipilimumab and nivolumab combo in advanced melanoma

Comment: CALGB/SWOG 80405 study on chemo combos in colorectal

T-VEC injections into melanoma lesions show significant response rate

ASCO 2014 roundup

Blinatumomab shown to be beneficial in relapsed/refractory B-precursor acute lymphoblastic leukaemia

Adjuvant exemestane is more effective than tamoxifen when combined with ovarian function suppression in young women with hormone-sensitive, early-stage breast cancer